Recombinant SARS-CoV-2 Nucleocapsid antibody

Catalog No. ABIN7574079

The Human Monoclonal anti-SARS-CoV-2 Nucleocapsid antibody has been validated for ELISA and WB. It is suitable to detect SARS-CoV-2 Nucleocapsid in samples from SARS Coronavirus-2 (SARS-CoV-2).

Quick Overview for Recombinant SARS-CoV-2 Nucleocapsid antibody (ABIN7574079)

Target: SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Antibody Type: Recombinant Antibody

Reactivity: SARS Coronavirus-2 (SARS-CoV-2)

Host: Human

Clonality: Monoclonal

Conjugate: This SARS-CoV-2 Nucleocapsid antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Clone: 2D2

Product Details anti-SARS-CoV-2 Nucleocapsid Antibody

Expression System: Mammalian cells

Purpose: Recombinant Anti-SARS-CoV-2 NP/Nucleoprotein antibody (2D2)

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1, kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 2.2 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: -20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks). Store at -20 °C 12 months. Store at -80°C long term.

Target Details for SARS-CoV-2 Nucleocapsid

Target: SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Alternative Name: SARS-CoV-2 NP

Target Type: Viral Protein

Background: Nucleoprotein,N,Nucleocapsid protein,NC,Protein N,N Protein, SARS-like Coronaviruses